nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Mycophenolate mofetil—systemic lupus erythematosus	0.159	0.249	CbGbCtD
Eprosartan—ABCC2—Cyclosporine—systemic lupus erythematosus	0.12	0.189	CbGbCtD
Eprosartan—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0862	0.136	CbGbCtD
Eprosartan—ABCC2—Dexamethasone—systemic lupus erythematosus	0.0791	0.124	CbGbCtD
Eprosartan—ABCC2—Methotrexate—systemic lupus erythematosus	0.0636	0.1	CbGbCtD
Eprosartan—CYP2C9—Dapsone—systemic lupus erythematosus	0.0614	0.0966	CbGbCtD
Eprosartan—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0404	0.0635	CbGbCtD
Eprosartan—CYP2C9—cardial valve—systemic lupus erythematosus	0.0279	0.337	CbGeAlD
Eprosartan—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0266	0.0418	CbGbCtD
Eprosartan—AGTR1—endothelium—systemic lupus erythematosus	0.00735	0.0887	CbGeAlD
Eprosartan—AGTR1—blood plasma—systemic lupus erythematosus	0.00653	0.0788	CbGeAlD
Eprosartan—CYP2C9—urine—systemic lupus erythematosus	0.00602	0.0727	CbGeAlD
Eprosartan—AGTR1—connective tissue—systemic lupus erythematosus	0.00348	0.0419	CbGeAlD
Eprosartan—AGTR1—nephron tubule—systemic lupus erythematosus	0.00337	0.0406	CbGeAlD
Eprosartan—CYP2C9—blood plasma—systemic lupus erythematosus	0.00314	0.0379	CbGeAlD
Eprosartan—AGTR1—kidney—systemic lupus erythematosus	0.00296	0.0357	CbGeAlD
Eprosartan—AGTR1—cortex of kidney—systemic lupus erythematosus	0.00288	0.0348	CbGeAlD
Eprosartan—AGTR1—lymphoid tissue—systemic lupus erythematosus	0.00254	0.0307	CbGeAlD
Eprosartan—ABCC2—nephron tubule—systemic lupus erythematosus	0.00243	0.0294	CbGeAlD
Eprosartan—AGTR1—tendon—systemic lupus erythematosus	0.00239	0.0288	CbGeAlD
Eprosartan—ABCC2—kidney—systemic lupus erythematosus	0.00214	0.0258	CbGeAlD
Eprosartan—AGTR1—lung—systemic lupus erythematosus	0.0021	0.0253	CbGeAlD
Eprosartan—ABCC2—cortex of kidney—systemic lupus erythematosus	0.00208	0.0251	CbGeAlD
Eprosartan—Losartan—ACE—systemic lupus erythematosus	0.00207	0.709	CrCbGaD
Eprosartan—AGTR1—nervous system—systemic lupus erythematosus	0.00194	0.0234	CbGeAlD
Eprosartan—AGTR1—central nervous system—systemic lupus erythematosus	0.00187	0.0226	CbGeAlD
Eprosartan—ABCC2—tendon—systemic lupus erythematosus	0.00173	0.0208	CbGeAlD
Eprosartan—AGTR1—Allograft Rejection—IL21—systemic lupus erythematosus	0.0013	0.0785	CbGpPWpGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—ACE—systemic lupus erythematosus	0.00108	0.065	CbGpPWpGaD
Eprosartan—Losartan—ALB—systemic lupus erythematosus	0.000846	0.291	CrCbGaD
Eprosartan—AGTR1—Allograft Rejection—C4A—systemic lupus erythematosus	0.000635	0.0384	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ETS1—systemic lupus erythematosus	0.000551	0.0333	CbGpPWpGaD
Eprosartan—ABCC2—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000521	0.0315	CbGpPWpGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—NOS3—systemic lupus erythematosus	0.000501	0.0302	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—FOXP3—systemic lupus erythematosus	0.000444	0.0268	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL17A—systemic lupus erythematosus	0.00035	0.0211	CbGpPWpGaD
Eprosartan—ABCC2—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000347	0.021	CbGpPWpGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—TGFB1—systemic lupus erythematosus	0.000331	0.02	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL12B—systemic lupus erythematosus	0.000325	0.0196	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CXCL12—systemic lupus erythematosus	0.000314	0.0189	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CD40—systemic lupus erythematosus	0.00031	0.0187	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CTLA4—systemic lupus erythematosus	0.000306	0.0185	CbGpPWpGaD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.0003	0.0181	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	0.000269	0.0163	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—F2—systemic lupus erythematosus	0.000266	0.0161	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	0.000252	0.0152	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL10—systemic lupus erythematosus	0.000238	0.0144	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CD40LG—systemic lupus erythematosus	0.000238	0.0144	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL4—systemic lupus erythematosus	0.000231	0.014	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.000227	0.0137	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—FASLG—systemic lupus erythematosus	0.000221	0.0133	CbGpPWpGaD
Eprosartan—Shock—Methylprednisolone—systemic lupus erythematosus	0.000214	0.00082	CcSEcCtD
Eprosartan—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000213	0.000816	CcSEcCtD
Eprosartan—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	0.000213	0.000816	CcSEcCtD
Eprosartan—Loss of consciousness—Betamethasone—systemic lupus erythematosus	0.000213	0.000816	CcSEcCtD
Eprosartan—Epistaxis—Methotrexate—systemic lupus erythematosus	0.000213	0.000816	CcSEcCtD
Eprosartan—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000213	0.000816	CcSEcCtD
Eprosartan—Rash—Leflunomide—systemic lupus erythematosus	0.000213	0.000815	CcSEcCtD
Eprosartan—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.000213	0.000815	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—FAS—systemic lupus erythematosus	0.000213	0.0129	CbGpPWpGaD
Eprosartan—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000213	0.000815	CcSEcCtD
Eprosartan—Nausea—Azathioprine—systemic lupus erythematosus	0.000213	0.000813	CcSEcCtD
Eprosartan—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000213	0.000813	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—IL2RA—systemic lupus erythematosus	0.000212	0.0128	CbGpPWpGaD
Eprosartan—Headache—Leflunomide—systemic lupus erythematosus	0.000212	0.00081	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000211	0.000808	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—systemic lupus erythematosus	0.000211	0.0128	CbGpPWpGaD
Eprosartan—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000211	0.000807	CcSEcCtD
Eprosartan—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000211	0.000806	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—C3—systemic lupus erythematosus	0.00021	0.0127	CbGpPWpGaD
Eprosartan—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.00021	0.000802	CcSEcCtD
Eprosartan—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.00021	0.000802	CcSEcCtD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000209	0.0126	CbGpPWpGaD
Eprosartan—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000208	0.000797	CcSEcCtD
Eprosartan—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000208	0.000796	CcSEcCtD
Eprosartan—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000207	0.000793	CcSEcCtD
Eprosartan—Myalgia—Betamethasone—systemic lupus erythematosus	0.000207	0.000791	CcSEcCtD
Eprosartan—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000207	0.000791	CcSEcCtD
Eprosartan—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000206	0.000789	CcSEcCtD
Eprosartan—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000206	0.000789	CcSEcCtD
Eprosartan—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000206	0.000788	CcSEcCtD
Eprosartan—Anxiety—Betamethasone—systemic lupus erythematosus	0.000206	0.000788	CcSEcCtD
Eprosartan—Discomfort—Betamethasone—systemic lupus erythematosus	0.000204	0.000781	CcSEcCtD
Eprosartan—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000204	0.000781	CcSEcCtD
Eprosartan—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000204	0.000781	CcSEcCtD
Eprosartan—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000204	0.000779	CcSEcCtD
Eprosartan—Pain—Prednisolone—systemic lupus erythematosus	0.000203	0.000777	CcSEcCtD
Eprosartan—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000202	0.000774	CcSEcCtD
Eprosartan—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000202	0.000771	CcSEcCtD
Eprosartan—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000202	0.000771	CcSEcCtD
Eprosartan—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000201	0.00077	CcSEcCtD
Eprosartan—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000201	0.00077	CcSEcCtD
Eprosartan—Nausea—Leflunomide—systemic lupus erythematosus	0.000201	0.000768	CcSEcCtD
Eprosartan—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.0002	0.000765	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000199	0.000761	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000199	0.000759	CcSEcCtD
Eprosartan—Pain—Hydrocortisone—systemic lupus erythematosus	0.000198	0.000759	CcSEcCtD
Eprosartan—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000198	0.000755	CcSEcCtD
Eprosartan—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000197	0.000754	CcSEcCtD
Eprosartan—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000196	0.00075	CcSEcCtD
Eprosartan—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000196	0.00075	CcSEcCtD
Eprosartan—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000196	0.000748	CcSEcCtD
Eprosartan—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000196	0.000748	CcSEcCtD
Eprosartan—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000196	0.000748	CcSEcCtD
Eprosartan—Shock—Dexamethasone—systemic lupus erythematosus	0.000195	0.000746	CcSEcCtD
Eprosartan—Shock—Betamethasone—systemic lupus erythematosus	0.000195	0.000746	CcSEcCtD
Eprosartan—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000195	0.000745	CcSEcCtD
Eprosartan—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000194	0.000742	CcSEcCtD
Eprosartan—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000194	0.000742	CcSEcCtD
Eprosartan—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000193	0.00074	CcSEcCtD
Eprosartan—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000193	0.00074	CcSEcCtD
Eprosartan—Angioedema—Prednisone—systemic lupus erythematosus	0.000193	0.000739	CcSEcCtD
Eprosartan—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000192	0.000735	CcSEcCtD
Eprosartan—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000192	0.000735	CcSEcCtD
Eprosartan—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000192	0.000734	CcSEcCtD
Eprosartan—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000192	0.000733	CcSEcCtD
Eprosartan—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000192	0.000733	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	0.000191	0.0116	CbGpPWpGaD
Eprosartan—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000191	0.000731	CcSEcCtD
Eprosartan—Malaise—Prednisone—systemic lupus erythematosus	0.000191	0.000729	CcSEcCtD
Eprosartan—Vertigo—Prednisone—systemic lupus erythematosus	0.00019	0.000727	CcSEcCtD
Eprosartan—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.00019	0.000725	CcSEcCtD
Eprosartan—Syncope—Prednisone—systemic lupus erythematosus	0.00019	0.000725	CcSEcCtD
Eprosartan—Tinnitus—Methotrexate—systemic lupus erythematosus	0.000189	0.000724	CcSEcCtD
Eprosartan—Anorexia—Betamethasone—systemic lupus erythematosus	0.000189	0.000722	CcSEcCtD
Eprosartan—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000189	0.000722	CcSEcCtD
Eprosartan—Urticaria—Prednisolone—systemic lupus erythematosus	0.000189	0.000722	CcSEcCtD
Eprosartan—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000188	0.00072	CcSEcCtD
Eprosartan—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000188	0.000719	CcSEcCtD
Eprosartan—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000188	0.000717	CcSEcCtD
Eprosartan—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000187	0.000716	CcSEcCtD
Eprosartan—Pain—Triamcinolone—systemic lupus erythematosus	0.000187	0.000714	CcSEcCtD
Eprosartan—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000186	0.000711	CcSEcCtD
Eprosartan—Hypotension—Betamethasone—systemic lupus erythematosus	0.000185	0.000708	CcSEcCtD
Eprosartan—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000185	0.000708	CcSEcCtD
Eprosartan—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000185	0.000706	CcSEcCtD
Eprosartan—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000184	0.000705	CcSEcCtD
Eprosartan—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000183	0.000701	CcSEcCtD
Eprosartan—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000183	0.000701	CcSEcCtD
Eprosartan—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000183	0.000699	CcSEcCtD
Eprosartan—Chills—Methotrexate—systemic lupus erythematosus	0.000182	0.000697	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.000181	0.0109	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000181	0.00069	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000181	0.00069	CcSEcCtD
Eprosartan—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.00018	0.000689	CcSEcCtD
Eprosartan—Arthralgia—Prednisone—systemic lupus erythematosus	0.00018	0.000688	CcSEcCtD
Eprosartan—Myalgia—Prednisone—systemic lupus erythematosus	0.00018	0.000688	CcSEcCtD
Eprosartan—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.00018	0.000688	CcSEcCtD
Eprosartan—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.00018	0.000687	CcSEcCtD
Eprosartan—Anxiety—Prednisone—systemic lupus erythematosus	0.000179	0.000686	CcSEcCtD
Eprosartan—Insomnia—Betamethasone—systemic lupus erythematosus	0.000179	0.000685	CcSEcCtD
Eprosartan—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000179	0.000685	CcSEcCtD
Eprosartan—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000179	0.000683	CcSEcCtD
Eprosartan—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000178	0.000681	CcSEcCtD
Eprosartan—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000178	0.000681	CcSEcCtD
Eprosartan—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000178	0.000681	CcSEcCtD
Eprosartan—Discomfort—Prednisone—systemic lupus erythematosus	0.000178	0.00068	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—CD80—systemic lupus erythematosus	0.000177	0.0107	CbGpPWpGaD
Eprosartan—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000175	0.000669	CcSEcCtD
Eprosartan—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000174	0.000667	CcSEcCtD
Eprosartan—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000174	0.000667	CcSEcCtD
Eprosartan—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000174	0.000666	CcSEcCtD
Eprosartan—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000174	0.000664	CcSEcCtD
Eprosartan—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000173	0.000662	CcSEcCtD
Eprosartan—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000173	0.00066	CcSEcCtD
Eprosartan—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000173	0.00066	CcSEcCtD
Eprosartan—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000172	0.000659	CcSEcCtD
Eprosartan—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000172	0.000659	CcSEcCtD
Eprosartan—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000172	0.000659	CcSEcCtD
Eprosartan—Back pain—Methotrexate—systemic lupus erythematosus	0.000171	0.000654	CcSEcCtD
Eprosartan—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000171	0.000654	CcSEcCtD
Eprosartan—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000171	0.000653	CcSEcCtD
Eprosartan—Fatigue—Betamethasone—systemic lupus erythematosus	0.000171	0.000653	CcSEcCtD
Eprosartan—Shock—Prednisone—systemic lupus erythematosus	0.00017	0.000649	CcSEcCtD
Eprosartan—Pain—Betamethasone—systemic lupus erythematosus	0.00017	0.000648	CcSEcCtD
Eprosartan—Pain—Dexamethasone—systemic lupus erythematosus	0.00017	0.000648	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—systemic lupus erythematosus	0.000169	0.0102	CbGpPWpGaD
Eprosartan—Tachycardia—Prednisone—systemic lupus erythematosus	0.000168	0.000644	CcSEcCtD
Eprosartan—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000168	0.000644	CcSEcCtD
Eprosartan—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000167	0.000638	CcSEcCtD
Eprosartan—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000166	0.000636	CcSEcCtD
Eprosartan—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000166	0.000635	CcSEcCtD
Eprosartan—Rash—Cyclosporine—systemic lupus erythematosus	0.000165	0.000629	CcSEcCtD
Eprosartan—Anorexia—Prednisone—systemic lupus erythematosus	0.000165	0.000629	CcSEcCtD
Eprosartan—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000164	0.000629	CcSEcCtD
Eprosartan—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000164	0.000628	CcSEcCtD
Eprosartan—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000164	0.000627	CcSEcCtD
Eprosartan—Headache—Cyclosporine—systemic lupus erythematosus	0.000164	0.000625	CcSEcCtD
Eprosartan—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000163	0.000625	CcSEcCtD
Eprosartan—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000163	0.000625	CcSEcCtD
Eprosartan—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000162	0.00062	CcSEcCtD
Eprosartan—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000162	0.00062	CcSEcCtD
Eprosartan—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000162	0.000619	CcSEcCtD
Eprosartan—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000161	0.000615	CcSEcCtD
Eprosartan—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000161	0.000614	CcSEcCtD
Eprosartan—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000161	0.000614	CcSEcCtD
Eprosartan—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00016	0.000613	CcSEcCtD
Eprosartan—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.00016	0.00061	CcSEcCtD
Eprosartan—Malaise—Methotrexate—systemic lupus erythematosus	0.000159	0.000609	CcSEcCtD
Eprosartan—Vertigo—Methotrexate—systemic lupus erythematosus	0.000159	0.000607	CcSEcCtD
Eprosartan—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000159	0.000607	CcSEcCtD
Eprosartan—Urticaria—Betamethasone—systemic lupus erythematosus	0.000157	0.000602	CcSEcCtD
Eprosartan—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000157	0.000602	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000157	0.000601	CcSEcCtD
Eprosartan—Dizziness—Prednisolone—systemic lupus erythematosus	0.000157	0.000601	CcSEcCtD
Eprosartan—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000157	0.000599	CcSEcCtD
Eprosartan—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000157	0.000599	CcSEcCtD
Eprosartan—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000157	0.000599	CcSEcCtD
Eprosartan—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000157	0.000599	CcSEcCtD
Eprosartan—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000157	0.000599	CcSEcCtD
Eprosartan—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000156	0.000598	CcSEcCtD
Eprosartan—Insomnia—Prednisone—systemic lupus erythematosus	0.000156	0.000597	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.000155	0.00939	CbGpPWpGaD
Eprosartan—Nausea—Cyclosporine—systemic lupus erythematosus	0.000155	0.000593	CcSEcCtD
Eprosartan—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000155	0.000593	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000155	0.00936	CbGpPWpGaD
Eprosartan—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000155	0.000591	CcSEcCtD
Eprosartan—Cough—Methotrexate—systemic lupus erythematosus	0.000154	0.00059	CcSEcCtD
Eprosartan—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000154	0.00059	CcSEcCtD
Eprosartan—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000153	0.000587	CcSEcCtD
Eprosartan—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000152	0.00921	CbGpPWpGaD
Eprosartan—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000152	0.000581	CcSEcCtD
Eprosartan—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000151	0.000578	CcSEcCtD
Eprosartan—Arthralgia—Methotrexate—systemic lupus erythematosus	0.00015	0.000575	CcSEcCtD
Eprosartan—Myalgia—Methotrexate—systemic lupus erythematosus	0.00015	0.000575	CcSEcCtD
Eprosartan—Chest pain—Methotrexate—systemic lupus erythematosus	0.00015	0.000575	CcSEcCtD
Eprosartan—Decreased appetite—Prednisone—systemic lupus erythematosus	0.00015	0.000574	CcSEcCtD
Eprosartan—Rash—Prednisolone—systemic lupus erythematosus	0.00015	0.000573	CcSEcCtD
Eprosartan—Dermatitis—Prednisolone—systemic lupus erythematosus	0.00015	0.000572	CcSEcCtD
Eprosartan—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000149	0.00057	CcSEcCtD
Eprosartan—Fatigue—Prednisone—systemic lupus erythematosus	0.000149	0.000569	CcSEcCtD
Eprosartan—Headache—Prednisolone—systemic lupus erythematosus	0.000149	0.000569	CcSEcCtD
Eprosartan—Discomfort—Methotrexate—systemic lupus erythematosus	0.000149	0.000569	CcSEcCtD
Eprosartan—Constipation—Prednisone—systemic lupus erythematosus	0.000148	0.000564	CcSEcCtD
Eprosartan—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000148	0.000564	CcSEcCtD
Eprosartan—AGTR1—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000147	0.00887	CbGpPWpGaD
Eprosartan—Rash—Hydrocortisone—systemic lupus erythematosus	0.000146	0.000559	CcSEcCtD
Eprosartan—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000146	0.000559	CcSEcCtD
Eprosartan—Headache—Hydrocortisone—systemic lupus erythematosus	0.000145	0.000556	CcSEcCtD
Eprosartan—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000144	0.000552	CcSEcCtD
Eprosartan—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000144	0.000551	CcSEcCtD
Eprosartan—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000142	0.000544	CcSEcCtD
Eprosartan—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000142	0.000544	CcSEcCtD
Eprosartan—Asthenia—Betamethasone—systemic lupus erythematosus	0.000142	0.000544	CcSEcCtD
Eprosartan—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000141	0.00054	CcSEcCtD
Eprosartan—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000141	0.00054	CcSEcCtD
Eprosartan—Nausea—Prednisolone—systemic lupus erythematosus	0.000141	0.00054	CcSEcCtD
Eprosartan—Pruritus—Betamethasone—systemic lupus erythematosus	0.00014	0.000536	CcSEcCtD
Eprosartan—Pruritus—Dexamethasone—systemic lupus erythematosus	0.00014	0.000536	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—IFNG—systemic lupus erythematosus	0.00014	0.00844	CbGpPWpGaD
Eprosartan—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000139	0.000533	CcSEcCtD
Eprosartan—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000139	0.000531	CcSEcCtD
Eprosartan—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000139	0.00053	CcSEcCtD
Eprosartan—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000138	0.000527	CcSEcCtD
Eprosartan—Rash—Triamcinolone—systemic lupus erythematosus	0.000138	0.000527	CcSEcCtD
Eprosartan—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000138	0.000526	CcSEcCtD
Eprosartan—Anorexia—Methotrexate—systemic lupus erythematosus	0.000138	0.000526	CcSEcCtD
Eprosartan—Rash—Methylprednisolone—systemic lupus erythematosus	0.000137	0.000525	CcSEcCtD
Eprosartan—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000137	0.000525	CcSEcCtD
Eprosartan—Urticaria—Prednisone—systemic lupus erythematosus	0.000137	0.000524	CcSEcCtD
Eprosartan—Headache—Triamcinolone—systemic lupus erythematosus	0.000137	0.000523	CcSEcCtD
Eprosartan—Headache—Methylprednisolone—systemic lupus erythematosus	0.000137	0.000522	CcSEcCtD
Eprosartan—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000136	0.000522	CcSEcCtD
Eprosartan—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000136	0.000522	CcSEcCtD
Eprosartan—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000136	0.000519	CcSEcCtD
Eprosartan—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000136	0.000519	CcSEcCtD
Eprosartan—Hypotension—Methotrexate—systemic lupus erythematosus	0.000135	0.000515	CcSEcCtD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000132	0.00794	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000131	0.000503	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000131	0.00793	CbGpPWpGaD
Eprosartan—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000131	0.000501	CcSEcCtD
Eprosartan—Dizziness—Betamethasone—systemic lupus erythematosus	0.000131	0.000501	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—systemic lupus erythematosus	0.00013	0.00788	CbGpPWpGaD
Eprosartan—Insomnia—Methotrexate—systemic lupus erythematosus	0.00013	0.000499	CcSEcCtD
Eprosartan—Nausea—Triamcinolone—systemic lupus erythematosus	0.00013	0.000496	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.00013	0.00783	CbGpPWpGaD
Eprosartan—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.00013	0.000495	CcSEcCtD
Eprosartan—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000129	0.000495	CcSEcCtD
Eprosartan—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000129	0.000492	CcSEcCtD
Eprosartan—Somnolence—Methotrexate—systemic lupus erythematosus	0.000128	0.00049	CcSEcCtD
Eprosartan—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000127	0.000486	CcSEcCtD
Eprosartan—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000127	0.000486	CcSEcCtD
Eprosartan—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000126	0.000482	CcSEcCtD
Eprosartan—Vomiting—Betamethasone—systemic lupus erythematosus	0.000126	0.000482	CcSEcCtD
Eprosartan—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000125	0.000479	CcSEcCtD
Eprosartan—Rash—Dexamethasone—systemic lupus erythematosus	0.000125	0.000478	CcSEcCtD
Eprosartan—Rash—Betamethasone—systemic lupus erythematosus	0.000125	0.000478	CcSEcCtD
Eprosartan—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000125	0.000477	CcSEcCtD
Eprosartan—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000125	0.000477	CcSEcCtD
Eprosartan—Fatigue—Methotrexate—systemic lupus erythematosus	0.000124	0.000476	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—IL2—systemic lupus erythematosus	0.000124	0.0075	CbGpPWpGaD
Eprosartan—Headache—Betamethasone—systemic lupus erythematosus	0.000124	0.000475	CcSEcCtD
Eprosartan—Headache—Dexamethasone—systemic lupus erythematosus	0.000124	0.000475	CcSEcCtD
Eprosartan—Asthenia—Prednisone—systemic lupus erythematosus	0.000124	0.000474	CcSEcCtD
Eprosartan—Pain—Methotrexate—systemic lupus erythematosus	0.000123	0.000472	CcSEcCtD
Eprosartan—Pruritus—Prednisone—systemic lupus erythematosus	0.000122	0.000467	CcSEcCtD
Eprosartan—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000119	0.000455	CcSEcCtD
Eprosartan—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000118	0.000452	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000118	0.00713	CbGpPWpGaD
Eprosartan—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000118	0.000451	CcSEcCtD
Eprosartan—Nausea—Betamethasone—systemic lupus erythematosus	0.000118	0.00045	CcSEcCtD
Eprosartan—Nausea—Dexamethasone—systemic lupus erythematosus	0.000118	0.00045	CcSEcCtD
Eprosartan—Urticaria—Methotrexate—systemic lupus erythematosus	0.000115	0.000438	CcSEcCtD
Eprosartan—Dizziness—Prednisone—systemic lupus erythematosus	0.000114	0.000436	CcSEcCtD
Eprosartan—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000114	0.000436	CcSEcCtD
Eprosartan—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000114	0.000436	CcSEcCtD
Eprosartan—Vomiting—Prednisone—systemic lupus erythematosus	0.00011	0.00042	CcSEcCtD
Eprosartan—Rash—Prednisone—systemic lupus erythematosus	0.000109	0.000416	CcSEcCtD
Eprosartan—Dermatitis—Prednisone—systemic lupus erythematosus	0.000109	0.000416	CcSEcCtD
Eprosartan—Headache—Prednisone—systemic lupus erythematosus	0.000108	0.000413	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	0.000107	0.00643	CbGpPWpGaD
Eprosartan—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000106	0.000406	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—VEGFA—systemic lupus erythematosus	0.000106	0.00638	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000104	0.0063	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.000104	0.00629	CbGpPWpGaD
Eprosartan—Asthenia—Methotrexate—systemic lupus erythematosus	0.000104	0.000396	CcSEcCtD
Eprosartan—ABCC2—NRF2 pathway—RXRA—systemic lupus erythematosus	0.000103	0.00622	CbGpPWpGaD
Eprosartan—Nausea—Prednisone—systemic lupus erythematosus	0.000103	0.000392	CcSEcCtD
Eprosartan—Pruritus—Methotrexate—systemic lupus erythematosus	0.000102	0.00039	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.000102	0.00615	CbGpPWpGaD
Eprosartan—Diarrhoea—Methotrexate—systemic lupus erythematosus	9.87e-05	0.000377	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—TGFB1—systemic lupus erythematosus	9.69e-05	0.00585	CbGpPWpGaD
Eprosartan—Dizziness—Methotrexate—systemic lupus erythematosus	9.54e-05	0.000365	CcSEcCtD
Eprosartan—AGTR1—G alpha (q) signalling events—F2—systemic lupus erythematosus	9.26e-05	0.00559	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	9.22e-05	0.00557	CbGpPWpGaD
Eprosartan—Vomiting—Methotrexate—systemic lupus erythematosus	9.17e-05	0.000351	CcSEcCtD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	9.17e-05	0.00554	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	9.14e-05	0.00552	CbGpPWpGaD
Eprosartan—Rash—Methotrexate—systemic lupus erythematosus	9.1e-05	0.000348	CcSEcCtD
Eprosartan—Dermatitis—Methotrexate—systemic lupus erythematosus	9.09e-05	0.000347	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—TNF—systemic lupus erythematosus	9.05e-05	0.00546	CbGpPWpGaD
Eprosartan—Headache—Methotrexate—systemic lupus erythematosus	9.04e-05	0.000346	CcSEcCtD
Eprosartan—Nausea—Methotrexate—systemic lupus erythematosus	8.57e-05	0.000328	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	8.34e-05	0.00504	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	8.28e-05	0.005	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	8.15e-05	0.00492	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL12—systemic lupus erythematosus	7.94e-05	0.00479	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	7.48e-05	0.00451	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	7.15e-05	0.00432	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	7.08e-05	0.00428	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	6.99e-05	0.00422	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	6.99e-05	0.00422	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	6.7e-05	0.00405	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	6.67e-05	0.00403	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	6.13e-05	0.0037	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	6.06e-05	0.00366	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	5.47e-05	0.0033	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCR5—systemic lupus erythematosus	5.44e-05	0.00329	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—C3—systemic lupus erythematosus	5.32e-05	0.00321	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	5.3e-05	0.0032	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—F2—systemic lupus erythematosus	4.67e-05	0.00282	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	4.49e-05	0.00271	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	4.19e-05	0.00253	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL2—systemic lupus erythematosus	4.16e-05	0.00251	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	4.08e-05	0.00246	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	3.97e-05	0.0024	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	3.8e-05	0.00229	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—TGFB1—systemic lupus erythematosus	3.7e-05	0.00223	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TLR9—systemic lupus erythematosus	3.69e-05	0.00223	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—P2RY12—systemic lupus erythematosus	3.58e-05	0.00216	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	3.38e-05	0.00204	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.3e-05	0.00199	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CSK—systemic lupus erythematosus	3.29e-05	0.00199	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	3.28e-05	0.00198	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	3.25e-05	0.00196	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	3.08e-05	0.00186	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	3.03e-05	0.00183	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NCF2—systemic lupus erythematosus	3.01e-05	0.00182	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—C3—systemic lupus erythematosus	3.01e-05	0.00181	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LYN—systemic lupus erythematosus	2.99e-05	0.00181	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—JAK1—systemic lupus erythematosus	2.95e-05	0.00178	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.94e-05	0.00177	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR5—systemic lupus erythematosus	2.79e-05	0.00169	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	2.75e-05	0.00166	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—C3—systemic lupus erythematosus	2.73e-05	0.00165	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—F2—systemic lupus erythematosus	2.64e-05	0.00159	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.41e-05	0.00145	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—F2—systemic lupus erythematosus	2.4e-05	0.00145	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—JUNB—systemic lupus erythematosus	2.36e-05	0.00143	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.25e-05	0.00136	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRL—systemic lupus erythematosus	2.18e-05	0.00131	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.14e-05	0.00129	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.94e-05	0.00117	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.87e-05	0.00113	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.78e-05	0.00107	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—JAK1—systemic lupus erythematosus	1.74e-05	0.00105	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR5—systemic lupus erythematosus	1.65e-05	0.000996	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.63e-05	0.000982	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL2—systemic lupus erythematosus	1.61e-05	0.000974	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—C3—systemic lupus erythematosus	1.61e-05	0.000974	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.52e-05	0.000921	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—F2—systemic lupus erythematosus	1.42e-05	0.000855	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CD80—systemic lupus erythematosus	1.36e-05	0.000819	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.26e-05	0.000762	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.21e-05	0.000731	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.15e-05	0.000692	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.12e-05	0.000679	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	9.74e-06	0.000588	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	9.63e-06	0.000581	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL2—systemic lupus erythematosus	9.53e-06	0.000576	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—systemic lupus erythematosus	9.49e-06	0.000573	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—systemic lupus erythematosus	9.02e-06	0.000545	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	8.99e-06	0.000543	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	8.66e-06	0.000523	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EP300—systemic lupus erythematosus	8.56e-06	0.000517	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.1e-06	0.000489	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	7.57e-06	0.000457	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.44e-06	0.000449	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	6.79e-06	0.00041	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.3e-06	0.00038	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—systemic lupus erythematosus	5.6e-06	0.000338	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	4.29e-06	0.000259	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	3.86e-06	0.000233	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	3.69e-06	0.000223	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	3.37e-06	0.000204	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	2.81e-06	0.000169	CbGpPWpGaD
